Pharmacotherapy: Aspirin discontinuation increases risk of cardiovascular events
Nat Rev Cardiol
.
2017 Dec;14(12):696-697.
doi: 10.1038/nrcardio.2017.160.
Epub 2017 Oct 12.
Author
Karina Huynh
PMID:
29022572
DOI:
10.1038/nrcardio.2017.160
No abstract available
Publication types
Comment
MeSH terms
Aspirin*
Cardiovascular Diseases*
Cohort Studies
Humans
Platelet Aggregation Inhibitors
Sweden
Substances
Platelet Aggregation Inhibitors
Aspirin